0.6242
price down icon1.70%   -0.0108
after-market 시간 외 거래: .63 0.0058 +0.93%
loading
전일 마감가:
$0.635
열려 있는:
$0.668
하루 거래량:
66,109
Relative Volume:
0.37
시가총액:
$10.54M
수익:
순이익/손실:
$-43.10M
주가수익비율:
-0.1005
EPS:
-6.2098
순현금흐름:
$-26.38M
1주 성능:
-17.88%
1개월 성능:
-48.41%
6개월 성능:
-72.13%
1년 성능:
-88.74%
1일 변동 폭
Value
$0.6201
$0.6688
1주일 범위
Value
$0.6201
$0.7775
52주 변동 폭
Value
$0.6201
$5.99

Tempest Therapeutics Inc Stock (TPST) Company Profile

Name
명칭
Tempest Therapeutics Inc
Name
전화
415-798-8589
Name
주소
2000 SIERRA POINT PARKWAY, BRISBANE
Name
직원
4
Name
트위터
Name
다음 수익 날짜
2026-11-04
Name
최신 SEC 제출 서류
Name
TPST's Discussions on Twitter

Compare TPST vs VRTX, MRNA, REGN, ARGX, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
TPST icon
TPST
Tempest Therapeutics Inc
0.6242 10.54M 0 -43.10M -26.38M -6.2098
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
499.74 126.66B 12.34B 4.34B 3.71B 16.87
MRNA icon
MRNA
Moderna Inc
218.01 87.04B 2.23B -3.19B -1.60B -8.1462
REGN icon
REGN
Regeneron Pharmaceuticals Inc
790.74 81.41B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
819.14 51.51B 4.16B 1.29B 734.26M 19.58
ONC icon
ONC
Beone Medicines Ltd Adr
369.06 41.75B 5.76B 514.49M 1.10B 4.4813

Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-01-22 업그레이드 H.C. Wainwright Neutral → Buy
2025-04-10 다운그레이드 H.C. Wainwright Buy → Neutral
2025-04-10 다운그레이드 Scotiabank Sector Outperform → Sector Perform
2024-03-14 개시 Scotiabank Sector Outperform
2024-02-08 개시 Jefferies Buy

Tempest Therapeutics Inc 주식(TPST)의 최신 뉴스

pulisher
Oct 14, 2026

With $0 left to sell, Tempest Therapeutics (TPST) reports a warrant offering. - Stock Titan

Oct 14, 2026
pulisher
Oct 02, 2026

Nancy Freda Smith Files Initial SEC Ownership Disclosure as New Director of Tempest Therapeutics - Kalkine Media

Oct 02, 2026
pulisher
Oct 02, 2026

A director receives 25,000 options with a $1 exercise price at Tempest Therapeutics (TPST). - Stock Titan

Oct 02, 2026
pulisher
Sep 23, 2026

Avalo Therapeutics, Inc. (AVTX) Stock Price, News, Quote & History - Yahoo Finance

Sep 23, 2026
pulisher
Sep 28, 2026

Form 8K Tempest Therapeutics Inc For: 28 September By Investing.com - Investing.com Australia

Sep 28, 2026
pulisher
Sep 28, 2026

Form 8K Tempest Therapeutics Inc For: 28 September By Investing.com - Investing.com Nigeria

Sep 28, 2026
pulisher
Sep 28, 2026

Form 8K Tempest Therapeutics Inc For: 28 September By Investing.com - Investing.com South Africa

Sep 28, 2026
pulisher
Sep 28, 2026

Form 8K Tempest Therapeutics Inc For: 28 September By Investing.com - Investing.com UK

Sep 28, 2026
pulisher
Sep 23, 2026

Tempest Therapeutics, Inc. (TPST) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 23, 2026
pulisher
Sep 17, 2026

Tempest Therapeutics, Inc.Common Stock (NQ: TPST - The Chronicle-Journal

Sep 17, 2026
pulisher
Sep 17, 2026

TPST Stock Slides As Dilutive Financing Overhang Builds - StocksToTrade

Sep 17, 2026
pulisher
Sep 16, 2026

TPST Stock Spikes As Tempest Therapeutics Expands In Vivo CAR-T Pipeline - timothysykes.com

Sep 16, 2026
pulisher
Sep 16, 2026

TPST Stock Jumps As Tempest Therapeutics Expands CAR-T Pipeline - timothysykes.com

Sep 16, 2026
pulisher
Sep 16, 2026

Why Tempest Therapeutics Shares Are Trading Higher By Around 50%; Here Are 20 Stocks Moving Premarket - Benzinga

Sep 16, 2026
pulisher
Sep 16, 2026

TPST Stock Spikes As Tempest Therapeutics Bets On In Vivo CAR-T - StocksToTrade

Sep 16, 2026
pulisher
Sep 16, 2026

TPST Stock Spikes As Tempest Therapeutics Expands In Vivo CAR-T Pipeline - Timothy Sykes

Sep 16, 2026
pulisher
Sep 15, 2026

Tempest Therapeutics Raises $2.5 Million in Private Placement - Minichart

Sep 15, 2026
pulisher
Sep 15, 2026

Form 8K Tempest Therapeutics Inc For: 15 September By Investing.com - Investing.com UK

Sep 15, 2026
pulisher
Sep 15, 2026

Tempest Therapeutics Gains Option to License New In-Body CAR-T Technology From Senlang - Yahoo Finance

Sep 15, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics raises $2.5M in private placement By Investing.com - Investing.com Australia

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics raises $2.5M in private placement By Investing.com - Investing.com Nigeria

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics, Inc. announced that it expects to receive $2.500001 million in funding - marketscreener.com

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics Announces Up to $7.5 Million Private Placement - markets.businessinsider.com

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics raises $2.5M in private placement By Investing.com - Investing.com Canada

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics raises $2.5M in private placement - Investing.com

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics raises $2.5M in private placement By Investing.com - Investing.com India

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics Announces Up to $7.5 Million Private Placement - The Manila Times

Sep 11, 2026
pulisher
Sep 11, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics raises $2.5M in private placement By Investing.com - Investing.com UK

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics Announces Up to $7.5 Million Private Placement - GlobeNewswire

Sep 11, 2026
pulisher
Sep 11, 2026

Tempest Therapeutics Announces Up to $7.5 Million Private Placement - Yahoo Finance

Sep 11, 2026
pulisher
Sep 08, 2026

Tempest Therapeutics CEO to present at H.C. Wainwright Global Investment Conference - Bitget

Sep 08, 2026
pulisher
Sep 08, 2026

A biotech CEO will speak Sept. 15; Tempest will archive the webcast - Stock Titan

Sep 08, 2026
pulisher
Sep 01, 2026

Tempest Therapeutics, Inc. SEC Filing (Sep 1, 2026) - Stock Titan

Sep 01, 2026
pulisher
Aug 29, 2026

Tempest Therapeutics (TPST) Slips 1.85% to $1.06 as Shares Test Support at $1.01Cup and Handle - siam.in

Aug 29, 2026
pulisher
Aug 29, 2026

Tempest Therapeutics (TPST) Slips 1.85% to $1.06 as Shares Test Support at $1.01Large Cap Trends - dars.gov.et

Aug 29, 2026
pulisher
Aug 24, 2026

Tempest TherapeuticsJustin Trojanowski To Resign As Principal Financial Officer And Principal Accounting Officer Effective Sept 1SEC Filing - tradingview.com

Aug 24, 2026
pulisher
Aug 23, 2026

Tempest (TPST) Results at a Glance: Reported EPS Misses Expectations at the Close; Trading Move: The Stock Records a 1.96% Increase in Latest TradingProfit Guidance Range - vinanet.vn

Aug 23, 2026
pulisher
Aug 21, 2026

Tempest Therapeutics secures $50M equity purchase agreement with Lincoln Park - scanx.trade

Aug 21, 2026
pulisher
Aug 21, 2026

Tempest Therapeutics files prospectus for sale of 8.9 million shares - scanx.trade

Aug 21, 2026
pulisher
Aug 21, 2026

Tempest Therapeutics (NASDAQ: TPST) lines up $50M stock facility that may heavily dilute holders - Stock Titan

Aug 21, 2026
pulisher
Aug 20, 2026

Tempest (TPST) Results Versus Estimates: The EPS Result Is Below Expectation in Latest Trading; Latest Reaction: The Stock Loses 4.58% in the Available RecordProfit Recovery Report - vinanet.vn

Aug 20, 2026
pulisher
Aug 20, 2026

Tempest partners Senlang to advance TPST-4003 in China trial - scanx.trade

Aug 20, 2026
pulisher
Aug 18, 2026

Form 8K Tempest Therapeutics Inc For: 18 August By Investing.com - Investing.com South Africa

Aug 18, 2026
pulisher
Aug 18, 2026

Tempest Therapeutics adjourns special meeting, sets new date for stockholder vote - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

Tempest Therapeutics Adjourns Special Stockholder Meeting Again - TipRanks

Aug 18, 2026
pulisher
Aug 18, 2026

Form 8K Tempest Therapeutics Inc For: 18 August By Investing.com - Investing.com Nigeria

Aug 18, 2026
pulisher
Aug 18, 2026

Tempest Therapeutics adjourns special meeting, sets new date for stockholder vote - Investing.com

Aug 18, 2026
pulisher
Aug 18, 2026

Form 8K Tempest Therapeutics Inc For: 18 August By Investing.com - Investing.com Canada

Aug 18, 2026
pulisher
Aug 18, 2026

Form 8K Tempest Therapeutics Inc For: 18 August By Investing.com - Investing.com India

Aug 18, 2026

Tempest Therapeutics Inc (TPST) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Tempest Therapeutics Inc 주식 (TPST) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Angel Matthew
CEO and President
Mar 24 '26
Buy
2.16
231,482
500,001
231,482
$6.58
price down icon 4.22%
$9.94
price down icon 3.21%
$5.53
price down icon 3.66%
$11.27
price down icon 6.16%
$18.60
price down icon 1.74%
WVE WVE
$3.13
price down icon 1.88%
자본화:     |  볼륨(24시간):